Guillain-Barré (GBS) & CIDP Testing Sydney | Nerve Conduction Study | East Neurology

Guillain-Barré & CIDP Testing in Sydney

Specialised nerve conduction studies for inflammatory neuropathy — Dr Ron Granot, FRACP, Bondi Junction. Same-day reports.

Phone (02) 9388 0615

🚨 If symptoms are rapidly progressive — go to Emergency

If you or your patient cannot walk independently, has shortness of breath, has weakness progressing within hours rather than days, or has bulbar symptoms (difficulty swallowing or speaking), attend the nearest Emergency Department or call 000. Suspected GBS in a deteriorating patient requires hospital admission for respiratory monitoring and immediate treatment — not outpatient testing.

Outpatient nerve conduction studies are appropriate for stable, ambulant patients where the diagnosis is uncertain, and for monitoring of established CIDP.

What are Inflammatory Neuropathies?

Inflammatory neuropathies are autoimmune disorders in which the immune system attacks peripheral nerves. The two best-recognised forms are:

GBS — Acute

Guillain-Barré syndrome. Develops over days to four weeks, often after a recent infection. Usually monophasic — patients deteriorate, reach a nadir, and recover (with treatment). Most common cause of acute flaccid paralysis in adults.

CIDP — Chronic

Chronic inflammatory demyelinating polyneuropathy. Develops over more than eight weeks. Runs a progressive or relapsing course. Requires long-term treatment (IVIG, plasma exchange, corticosteroids).

MMN

Multifocal motor neuropathy. Asymmetric motor weakness without sensory involvement. Often mistaken for motor neurone disease early. NCS shows characteristic conduction block.

Other variants

Miller Fisher syndrome (ophthalmoplegia, ataxia, areflexia), MADSAM (multifocal acquired demyelinating sensory and motor neuropathy), DADS (distal acquired demyelinating symmetric neuropathy). NCS phenotype guides classification and treatment.

Symptoms That Should Trigger Testing

Pattern: Progressive symmetrical weakness developing over days (GBS) or weeks to months (CIDP), often beginning in the feet and ascending. Reflexes lost early — frequently before significant weakness — a key clinical clue.

Walking Difficulty

Progressively unsteady gait, weakness rising from a chair or climbing stairs.

Hand Weakness

Grip weakening, dropping objects, difficulty with buttons or keys.

Sensory Disturbance

Numbness, tingling or unsteadiness, often more prominent in CIDP than in pure MMN.

Loss of Reflexes

Ankle and knee reflexes typically lost early — a critical clinical finding that distinguishes inflammatory neuropathy from many alternatives.

Bulbar Symptoms

Swallowing difficulty, slurred speech, or facial weakness — features of more severe or atypical GBS. Requires emergency assessment.

Recent Trigger

GBS commonly follows a recent viral or bacterial infection (Campylobacter, CMV, EBV, hepatitis), surgery, or rarely vaccination. CIDP rarely has a clear trigger.

The Demyelinating Signature on NCS

Inflammatory neuropathies produce characteristic findings that distinguish them from axonal neuropathies (e.g. diabetic) — the difference matters because demyelinating neuropathies often respond well to immunomodulatory treatment.

FeatureDemyelinating (GBS / CIDP)Axonal neuropathy
Conduction velocityMarkedly slowed (often <75% of normal)Normal or mildly reduced
Distal motor latencyProlongedNormal
F-wavesProlonged or absent (early sign in GBS)Normal
Conduction blockPresentAbsent
Temporal dispersionPresentAbsent
CMAP amplitudeVariable, may be reducedReduced (primary finding)
Treatment responseIVIG, plasma exchange (CIDP also corticosteroids)Treat underlying cause

What to Expect at Your Test

1

Clinical assessment

Dr Granot reviews the symptom timeline, examines for reflex changes and weakness pattern, and assesses whether outpatient testing is appropriate or hospital referral is needed.

2

Comprehensive NCS battery

Motor and sensory studies in multiple nerves of upper and lower limbs. F-wave studies to detect proximal demyelination — particularly important in early GBS where peripheral findings may still be mild.

3

Needle EMG if indicated

Sampling of selected muscles to assess for active denervation (axonal involvement), motor unit recruitment, and chronicity. Adds important prognostic information.

4

Same-day discussion and report

Findings discussed immediately, classification (demyelinating vs axonal, GBS vs CIDP) explained. Formal report to your referring doctor the same day. Direct phone discussion for urgent or complex cases.

Frequently Asked Questions

What is Guillain-Barré syndrome? +
An autoimmune attack on peripheral nerves causing progressive weakness, usually starting in the feet, developing over days to a week. The most common cause of acute flaccid paralysis in adults. Hospital admission with IVIG or plasma exchange is the standard of care.
How urgent is testing? +
Rapidly deteriorating patients should go to Emergency, not for outpatient NCS. Outpatient studies are appropriate for stable, ambulant patients with diagnostic uncertainty, and for monitoring established CIDP.
What does NCS show in GBS or CIDP? +
Demyelinating features: slowed conduction velocity, prolonged distal motor latencies, prolonged or absent F-waves, conduction block, and temporal dispersion. F-wave abnormalities may appear before peripheral slowing in early GBS.
Can NCS monitor treatment response? +
Yes — sequential NCS is useful in CIDP to assess response to treatment, guide treatment frequency, and detect early relapse.
What is the difference between GBS and CIDP? +
GBS develops over days to four weeks and is monophasic. CIDP develops over more than eight weeks and is chronic or relapsing. NCS features overlap; time course is the key distinction.
Will I get the results on the day? +
Yes — preliminary findings discussed immediately, formal report the same day. Direct phone discussion with the referrer for urgent suspected GBS.

For Urgent or Routine Inflammatory Neuropathy Testing

Phone the rooms to discuss timing • Same-day reports • Direct neurologist line for urgent cases

Call (02) 9388 0615
.